Category Archives: Stem Cell Research

The global longevity and anti-senescence therapies market should grow from $329.8 million in 2018 to $644.4 million by 2023 with a compound annual growth rate (CAGR) of 14.3% during 2018-2023. Report Scope: The scope of this report is broad and covers various therapies currently under trials in the global longevity and anti-senescence therapy market. The market estimation has been performed with consideration for revenue generation in the forecast years 2018-2023 after the expected availability of products in the market by 2023 Continue reading →

BEIJING: Chinese researchers are studying the use of stem cell technology in the treatment of people critically ill with the novel coronavirus disease (Covid-19), according to the Science and Technology Daily. Four Covid-19 patients who received stem cell treatment while in a serious condition have been discharged from hospital after recovery, and the clinical trial of the therapy will be further expanded, Vice-Minister of Science and Technology Xu Nanping was quoted by the paper as saying. Stem cells can self-renew or multiply while maintaining the potential to develop into other types of cells. Continue reading →

Cell Therapy Market Size, Share & Trends Analysis Report By Use-type (Research, Commercialized, Musculoskeletal Disorders), By Therapy Type (Autologous, Allogeneic), By Region, And Segment Forecasts, 2020 - 2027 New York, March 05, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Cell Therapy Market Size, Share & Trends Analysis Report By Use-type, By Therapy Type, By Region And Segment Forecasts, 2020 - 2027" - https://www.reportlinker.com/p05868803/?utm_source=GNW The global cell therapy market size is expected to reach USD 8.8 billion by 2027 at a CAGR of 5.4% over the forecast period. Cellular therapies hold a great therapeutic promise across various clinical applications Continue reading →

The success of approved stem cell therapies has caused a surge in interest of biopharma developers in this field; many innovator companies are currently progressing proprietary leads across different phases of clinical development, with cautious optimism LONDON, March 4, 2020 /PRNewswire/ -- Roots Analysishas announced the addition of "Global Stem Cells Market: Focus on Clinical Therapies, 20202030 (Based on Source (Allogeneic, Autologous); Origin (Adult, Embryonic); Type (Hematopoietic, Mesenchymal, Progenitor); Lineage (Amniotic Fluid, Adipose Tissue, Bone Marrow, Cardiosphere, Chondrocytes, Corneal Tissue, Cord Blood, Dental Pulp, Neural Tissue Placenta, Peripheral Blood, Stromal Cells); and Potency (Multipotent, Pluripotent))" report to its list of offerings. There is a growing body of evidence supporting the vast applicability and superiority of treatment outcomes of stem cell therapies, compared to conventional treatment options. In fact, the unmet needs within this domain have spurred the establishment of many start-ups in recent years. Continue reading →

The biopharma space has stepped up its efforts to both prevent and treat the coronavirus (SARS-CoV-2) that is threatening to bring the world to its knees. A month is a very long time when it comes to infectious diseases. Continue reading →

Coherent Market Insights published informative report on Global Stem Cell Therapy Market presents market size, historical breakdown data (20142019) and forecast (20202027). The report encompass insightful data on the main sectors of the global market Continue reading →

In the latest report on Stem Cell Antibody Market, added by UpMarketResearch.com, a concise analysis on the recent industry trends is covered. The report further includes statistics, market forecasts and revenue estimations that in addition highlights its status in the competitive domain as well as expansion trends adopted by major industry players. The report is a detailed study on the Stem Cell Antibody Market with details regarding an in-depth assessment of the industry vertical. Continue reading →

The Global Stem Cells Market is expected to grow from USD 115.46 Million in 2018 to USD 325.84 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 15.97%. The Stem Cells Market research presents a study by combining primary as well as secondary research Continue reading →

The Induced Pluripotent Stem Cells (iPSCs) MarketReport 2020 gives a clear understanding of the current market situation which includes of antique and projected upcoming market size based on technological growth, value and volume, projecting cost-effective and leading fundamentals in the Induced Pluripotent Stem Cells (iPSCs) market. Induced Pluripotent Stem Cells (iPSCs) industry report is to recognize, explain and forecast the global Induced Pluripotent Stem Cells (iPSCs) industry based on various aspects such as explanation, application, organization size, distribution mode, region Continue reading →

Read Time: Since Yamanakas demonstration in 2006 that adult cells can be reprogrammed to an embryonic stem cell-like state using a specific cocktail of transcription factors, interest in the development and use of induced pluripotent stem cells (iPSC) has flourished. Continue reading →